Distributor Obligations. Distributor shall:
Distributor Obligations. The Distributor must comply with the Electricity (Hazards from Trees) Regulations 2003.
Distributor Obligations. During the Term, Distributor shall: Shipment of Products and Instruments. Subject to Product availability and the terms and conditions of this Agreement, Distributor shall use reasonable efforts to fill Subdistributor’s orders for Products and Instruments, which are accepted by Distributor. It is understood by the Parties that expected delivery times will vary according to manufacturing and other conditions and that all delivery dates are estimates.
Distributor Obligations. In order to provide maximum protection and quality service to each of the Party’s customers, when acting as a distributor of the other party’s products (in each such instance, referred to herein as a “Distributor”) HBIO and XXXX each agree to comply with the following obligations. Failure to achieve and maintain such compliance shall constitute a material breach of this Agreement.
Distributor Obligations. Subject to Section 7, Supplier shall not terminate its obligation to supply Buyer's System nor shall Supplier withhold delivery of Product from any non-defaulting member of Buyer's System or any non-defaulting Distributor due to nonpayment or other default by a Distributor or a member of Buyer's System.
Distributor Obligations. Buyer shall not terminate its obligation to purchase, or cause to be purchased, Product from Supplier due to nonpayment or other default by a Distributor.
Distributor Obligations. At its own expense, Distributor shall use its best efforts to obtain all necessary Marketing Authorizations within the Territory. Specifically, Distributor agrees that it will undertake to manage, at Distributor’s expense, all animal trials and human clinical trials required to obtain the Marketing Authorizations. These approvals will be obtained jointly in the name of Micrus and Distributor. Upon termination of this Agreement, Distributor agrees to transfer all of its rights, title and interest in and to such approvals to Micrus, or any third party as may be designated in writing by Micrus. Distributor shall provide Micrus with written quarterly progress reports of its efforts to obtain Marketing Authorizations. Distributor agrees not to sell or distribute the Product in any geographic region within the Territory until such time as all Marketing Authorizations in such geographic region have duly been obtained, and to act at all times in a manner consistent with such Marketing Authorizations.
Distributor Obligations. Distributor may receive from Atossa, or create or receive on behalf of Atossa, health information that is protected under applicable state and/or federal law, including without limitation, PHl and EPHI. All capitalized terms not otherwise defined in this Agreement shall have the meaning s set forth in the Privacy Standards, Security Standards or the HlTECH Act, as applicable (collectively referred to hereinafter as the "Confidentiality Requirements"). All references to PHI herein shall be construed to include EPHI. Distributor agrees not to use or disclose (or permit the use or disclosure of) PHI in a manner that would violate the Confidentiality Requirements if the PHI were used or disclosed by Atossa in the same manner.
Distributor Obligations. If Distributor selects the Bulk Form (as defined in Exhibit A) of the Product, in whole or in part, Distributor shall obtain all required marketing approvals (if any) from the FDA or its foreign equivalent in every country in which Distributor promotes, markets or sells the resulting products. Distributor shall not promote, market or sell products resulting, in whole or in part, from the Bulk Form of the Product in a country unless and until Distributor has obtained such required marketing approval in such country. Distributor shall comply with all applicable regulatory requirements in any country in which Distributor promotes, markets or sells the Products or any products resulting from, in whole or in part, the Products. Distributor shall only sell the completed Vial Form (as defined in Exhibit A), and shall not re-sell the Bulk Form. In order for Halozyme to comply with Quality Systems Regulations (QSR’s) as promulgated by FDA and other regulatory authorities, Distributor must report to Halozyme any product complaints regarding the Product, within fourteen (14) days of the Distributor being informed of such complaint.
Distributor Obligations. In order to induce COMPANY to enter into this Agreement, and as a condition of its continuation in force, DISTRIBUTOR agrees that it will:
